Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
37 studies found for:    " June 18, 2008":" July 18, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc
Condition: HIV Infections
Intervention: Drug: Maraviroc
22 Unknown  Effectiveness of Antiretroviral Therapy During Acute HIV Infection
Condition: HIV Infections
Interventions: Drug: Highly Active Antiretroviral Therapy (HAART);   Other: No treatment
23 Completed Healthy Activities for Prize Incentives
Conditions: Substance Abuse;   HIV Infections
Intervention: Behavioral: contingency management
24 Unknown  Social-Psychological Intervention to Improve Adherence to HAART
Conditions: AIDS;   HIV Infections
Interventions: Behavioral: Social-psycho intervention to improve adherence to HAART;   Other: Usual care
25 Completed Effectiveness of a Community-level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-risk Populations
Conditions: HIV Infections;   Sexually Transmitted Diseases
Interventions: Behavioral: Community Popular Opinion Leader (C-POL);   Behavioral: HIV/STD educational materials
26 Completed Linkage to Care - Part I
Condition: HIV
Intervention:
27 Withdrawn Directly Administered Antiretroviral Therapy (DAART) Among HIV-1infected Injecting Drug Users (IDUs) in Chennai, India
Conditions: HIV Infections;   Heroin Dependence
Interventions: Behavioral: Directly Administered Antiretroviral Therapy (DAART);   Behavioral: SAT
28 Completed
Has Results
Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function
Condition: Human Immunodeficiency Virus (HIV) Infection
Interventions: Drug: Maraviroc;   Drug: Ritonavir;   Drug: Saquinavir
29 Completed Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART
Conditions: HIV Infections;   Malaria
Interventions: Drug: Lamivudine;   Drug: Lopinavir/Ritonavir;   Drug: Nevirapine;   Drug: Zidovudine
30 Completed
Has Results
Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: lopinavir/ritonavir (LPV/r);   Drug: emtricitabine/tenofovir disoproxil fumarate (FTC/TDF);   Drug: raltegravir (RAL)
31 Completed
Has Results
Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1349572;   Drug: Placebo
32 Completed Psychosocial Needs of YMSM
Condition: HIV+ YMSM
Intervention:
33 Withdrawn Maraviroc Compassionate Use
Condition: Human Immunodeficiency Virus Type 1
Intervention: Drug: Maraviroc
34 Terminated HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy
Condition: HIV-1 Infection
Intervention: Other: blood drawing
35 Completed GSK706769 Repeat Dose Study
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK706769
36 Completed Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients
Condition: Hepatitis C
Intervention:
37 Terminated Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy
Condition: Malaria in Pregnancy
Interventions: Drug: Cotrimoxazole;   Drug: Sulfadoxine-pyrimethamine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page   
Study has passed its completion date and status has not been verified in more than two years.